• An extraordinary general meeting was held on July 27, 2026.
• Shareholders passed a resolution to approve, ratify, and confirm the Subscription and Settlement Agreement; the agreement itself was not reported as executed.
• The meeting also authorized the issue of Convertible Bonds, plus the allotment and issue of new Shares on conversion.
• Directors received a specific mandate to allot and issue the Conversion Shares under the Convertible Bonds’ terms.
• The resolution further authorized a director to take actions needed to implement the agreement; no completion of the transactions was confirmed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosysen Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260727-12257572), on July 27, 2026, and is solely responsible for the information contained therein.